The development of artificial intelligence is becoming more and more mature, and has
penetrated into every field of clinical trials. Artificial intelligence has brought new …

Inside Precision Medicine's inaugural issue focused on artificial intelligence (AI)–namely,
how it can help solve the population health crisis and predict early warning signs of chronic …

Mandatory sharing of individual-level data from clinical trials with the research community
promises to accelerate medical research and improve public health. Clinical trial data …

Healthcare is one of the sectors where artificial intelligence (AI) is currently viewed as a
crucial driving factor. Patient care, medical research, and clinical trial enrollment could all …

This editorial continues a series focused on improving the credibility, transparency,
reproducibility, and replicability of biomedical informatics research. 1, 2 It addresses the new …

Transparency brings benefits to study participants, clinical trial sponsors, regulators, the
scientific community, and, ultimately, patients. 1-4 Disclosing trial information can inform …

The confluence of privacy-preserving techniques, big data solutions, and regulatory
compliance has ushered in a new era in healthcare. This paper explores the key findings …

Recent EU initiatives and legislation considerably increases public access to clinical trials
data (CTD). These are generally much welcomed developments for the enhancement of …

Recent European initiatives, including the European Medicines Agency (EMA)'s publication
and access to clinical trial data draft policy, have brought the issue of data transparency to …

Introduction: Clinical trials provide the “gold standard” evidence for advancing the practice of
medicine, even as they evolve to integrate real-world data sources. Modern clinical trials are …